Chen Yu-Wen, Lai Yung-Chang, Hsu Chien-Chin, Chuang Ya-Wen, Hou Ming-Feng
Department of Nuclear Medicine, Chou-Ho Memorial Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.
Kaohsiung J Med Sci. 2005 Jun;21(6):251-7. doi: 10.1016/S1607-551X(09)70197-4.
Sentinel lymph node (SLN) biopsy is an alternative to axillary node dissection for staging breast cancer treatment. In this article, we investigated nodal drainage patterns and tumor location using lymphoscintigraphy to predict the axillary sentinel lymph node status. We enrolled 88 patients with clinically suspicious or biopsy-proven breast cancer from March 2001 to October 2002. The average age of subjects was 48 +/- 4 years and the clinical stage was T(1-2)N0Mx. Tc-99m sulfur colloid was used in a hybrid combination of subdermal and perilesional injections around the selected comers of the tumor or biopsy site. Sentinel lymphoscintigraphy was performed 16-20 hours before surgery. Sentinel nodes were marked on the skin. An intraoperative gamma probe was used to confirm the sentinel lymph node location before biopsy. Most primary tumors were in the outer upper quadrant (52.3%), followed by the inner upper quadrant (17.0%), outer inferior quadrant (12.5%), central areolar area (11.4%), and inner inferior quadrant (6.8%). The nodal drainage patterns on 2-hour lymphoscintigraphy were as follows: axillary alone (76.1%), internal mammary nodes alone (1.1%), both axillary and internal mammary nodes (11.4%), and no drainage (11.4%). Internal mammary lymphatic drainage is related to tumor location in the inner quadrants of the breast. About 11.4% of all patients had poorly identified SLNs on lymphoscintigraphy within a 2-hour period, but there was improvement in the overall detection rate up to 95% by intraoperative gamma probe the next day. Preoperative lymphoscintigraphic mapping has value in providing individual lymphatic drainage patterns and tumor location that are important in the interpretation of the results of SLN biopsy during surgery.
前哨淋巴结(SLN)活检是乳腺癌治疗分期中腋窝淋巴结清扫术的替代方法。在本文中,我们使用淋巴闪烁显像术研究了淋巴结引流模式和肿瘤位置,以预测腋窝前哨淋巴结状态。我们纳入了2001年3月至2002年10月期间88例临床可疑或活检证实为乳腺癌的患者。受试者的平均年龄为48±4岁,临床分期为T(1 - 2)N0Mx。在肿瘤或活检部位选定角周围采用皮下和病变周围注射混合的方式使用锝-99m硫胶体。术前16 - 20小时进行前哨淋巴闪烁显像。在前哨淋巴结处做皮肤标记。术中使用γ探测仪在活检前确认前哨淋巴结位置。大多数原发性肿瘤位于外上象限(52.3%),其次是内上象限(17.0%)、外下象限(12.5%)、乳晕中央区(11.4%)和内下象限(6.8%)。2小时淋巴闪烁显像的淋巴结引流模式如下:仅腋窝(76.1%)、仅内乳淋巴结(1.1%)、腋窝和内乳淋巴结均有(11.4%)以及无引流(11.4%)。内乳淋巴引流与乳房内象限的肿瘤位置有关。在2小时内,约11.4%的所有患者在前哨淋巴闪烁显像中前哨淋巴结显示不清,但次日通过术中γ探测仪总体检出率提高到了95%。术前淋巴闪烁显像图谱对于提供个体淋巴引流模式和肿瘤位置具有价值,这对于术中解释前哨淋巴结活检结果很重要。